Members Of US Congress Seek Pressure On India Over IP Rights

A large portion of the United States Congress this week signed on to a letter to President Obama criticising India for its treatment of intellectual property rights.

Experts Propose Principles For IP Provisions In Bilateral, Regional Agreements

For several years, research at the Max Planck Institute for Intellectual Property and Competition Law (MPI) – in collaboration with experts from all over the world – has examined the trend of bilateral and regional agreements that include provisions on the protection and enforcement of intellectual property rights.

Visually Impaired, Civil Society, Industry Defend Their Stakes In Marrakesh

This week's World Intellectual Property Organization Marrakesh Diplomatic Conference, anticipated to deliver an international treaty allowing visually impaired people wider access to books, is also an arena where different stakeholders hope to influence the debate. Civil society calls for a practical treaty that really works on the ground, while industry insists that safeguards to protect the integrity of the international copyright laws be included in the treaty.

WIPO VIP Treaty: Opening Statements Lay Out Differences

Displays of good intentions peppered the two first days of World Intellectual Property Organization negotiations on treaty facilitating access to books for visually impaired people. However, countries pleading for flexibility reaffirmed their previous positions. Developed countries seeking to preserve the international copyright system, and developing countries assuring that the treaty is not jeopardising this system.

New Draft Text Issued By WIPO Negotiators For Visually Impaired Treaty

World Intellectual Property Organization delegates this week have launched into negotiations expected to yield the first treaty creating exceptions and limitations to copyright for the benefit of visually impaired people. Many delegations have said much work remained to be done in the next ten days to breach differences. A new text was released this evening on commercial availability.

European Commission Fines Pharma Companies For Payments To Delay Generic Entry

The European Commission (EC) has fined Danish pharmaceutical company Lundbeck as well as eight other generic manufacturers for delaying market entry of generic medicines by way of patent settlement agreements (also known as “pay-for-delay” agreements).

The Impact Of Derailing The WHO Medical R&D Convention

An article in the newly launched Journal of Health Diplomacy about the stalled progress at the World Health Organization for a medical research and development (R&D) convention discusses systemic failures in global health policy.

WIPO Seminar Discusses Impact Of TRIPS On Pharmaceutical Innovation

The latest instalment of the World Intellectual Property Organization seminar series titled “The Economics of Intellectual Property” covered the issue of product patents in the pharmaceutical industry. Discussion focussed on the economics of intellectual property rights and how pharmaceutical patent protection might not be the sole culprit in the access to innovation problem.